PBSV Company Profile and Key Details

Average 10-day trading volume of 1.74 thousand shares is below the 3-month average of 3.60 thousand, indicating normal recent market interest.

Pharma-Bio Serv, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended March 17, 2026, missed forecasts by -93.0%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include -97.67% in January 29, 2025.

The stock is currently mid-range between its 52-week high and low $0.43 and $1.36. With a market capitalization of about $13.05 million, Pharma-Bio Serv, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.65). Key stats such as the average daily volume over the past year has been around 839.00 shares, trading with heavier-than-usual volume. Headquartered in Dorado, PR, Pharma-Bio Serv, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Victor Sanchez, the company employs approximately 75 people and listed since May 07, 2007. Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm.

Pharma-Bio Serv, Inc. trades at a P/E ratio of -171.48, slightly below the S&P 500 average, with a price-to-sales ratio of 0.01 The P/FCF stands at -0.08, also above market averages.

Pharma-Bio Serv, Inc. last paid a dividend of 0.07 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.20. This means the shares are trading above this model’s fair value.

Valuation shows Pharma-Bio Serv, Inc. trading at a premium to the broader market with a P/E of -171.48.

Our AI price prediction model suggests that Pharma-Bio Serv, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.